{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:16:46Z","timestamp":1761855406092,"version":"build-2065373602"},"reference-count":73,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Salivary gland cancers (SGCs) are rare and comprise multiple histologic entities. In the recurrent or metastatic (R\/M) setting, there is limited evidence for effective systemic anticancer treatment for most subtypes, affecting prognosis and quality of life. Molecular analysis of SGCs holds promise to more accurately classify SGC subtypes and to determine novel therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>Fifteen patients with R\/M SGC underwent tumor biopsy and blood sampling to perform whole-genome sequencing (WGS) of tumor and germline as part of their standard-of-care management. Small somatic mutations, structural alterations, copy number variation, and mutational signatures were processed using WGS pipelines alongside germline testing. Alterations were correlated to clinical features and fed back to clinical team to inform treatment decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      WGS quality control was acceptable in 14 of 15 patients (adenoid cystic carcinoma [AdCC, n = 10], salivary duct carcinoma ex pleomorphic adenoma [n = 1]; clear cell myoepithelial carcinoma [n = 1]; epithelial-myoepithelial carcinoma [n = 1]; and acinic cell carcinoma [n = 1]). Genomic rearrangements\/fusions were present in 12 of 14. Rearrangements involving MYB and or NFIB were identified in 8 of 10 patients with AdCC. One patient harbored a clinically actionable\n                      <jats:italic toggle=\"yes\">FGFR1<\/jats:italic>\n                      -\n                      <jats:italic toggle=\"yes\">pleomorphic adenoma gene 1<\/jats:italic>\n                      fusion and responded to fibroblast growth factor receptor\u2013targeted therapy, in addition to enabling histologic reclassification. Other fusions included\n                      <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                      -\n                      <jats:italic toggle=\"yes\">ATF1<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">CRTC1<\/jats:italic>\n                      -\n                      <jats:italic toggle=\"yes\">MAML2<\/jats:italic>\n                      , which also aided definitive histologic classification. Small somatic alterations were identified in all but one patient. There were no pathogenic germline mutations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>WGS in SGC is achievable in clinically relevant timeframes, providing genomic information for deeper understanding of disease pathophysiology, to clarify histologic subtype and can identify actionable genomic targets which may not be found through routine sequencing technologies. Further use of WGS has the potential to improve care for patients with SGC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/po-25-00490","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:10:53Z","timestamp":1761855053000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5825-3241","authenticated-orcid":true,"given":"Matt","family":"Church","sequence":"first","affiliation":[{"name":"The Christie NHS Foundation Trust, Manchester, United Kingdom"},{"name":"The University of Manchester, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9360-8194","authenticated-orcid":true,"given":"George","family":"Burghel","sequence":"additional","affiliation":[{"name":"The University of Manchester, Manchester, United Kingdom"},{"name":"Manchester University NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Betts","sequence":"additional","affiliation":[{"name":"Manchester University NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Michael","family":"Churchill","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene Barbara","family":"Schlecht","sequence":"additional","affiliation":[{"name":"Manchester University NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yatin","family":"Jain","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6014-348X","authenticated-orcid":true,"given":"Kevin","family":"Harrington","sequence":"additional","affiliation":[{"name":"Royal Marsden NHS Foundation Trust, London, United Kingdom"},{"name":"The Institute of Cancer Research, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Metcalf","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust, Manchester, United Kingdom"},{"name":"The University of Manchester, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10006-012-0350-9"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-022-01420-1"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181d9efcc"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100602"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21316"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23467"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5356-3"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2016.10.018"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24745"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103745"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac080"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00378-9"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00541-1"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00545"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx771"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70245-X"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0424-4"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02682-0"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2024.04.018"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02382-1"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22981"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106759"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2016.10.002"},{"key":"e_1_3_7_25_2","unstructured":"NHS England: National Genomic Test Directory. 2018. https:\/\/www.england.nhs.uk\/publication\/national-genomic-test-directories\/"},{"key":"e_1_3_7_26_2","first-page":"273","article-title":"The new genomic medicine service and implications for patients","volume":"19","author":"Barwell J","year":"2019","unstructured":"Barwell J, Snape K, Wedderburn S: The new genomic medicine service and implications for patients. Clin Med (Lond) 19:273-277, 2019","journal-title":"Clin Med (Lond)"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0060-1"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx445"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2020.08.007"},{"key":"e_1_3_7_30_2","unstructured":"COSMIC. Signatures of Mutational Processes in Human Cancer. 2015. https:\/\/cancer.sanger.ac.uk\/signatures\/signatures_v2\/"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.11.030"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02156-6"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210961"},{"key":"e_1_3_7_35_2","first-page":"106","article-title":"PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II","volume":"60","author":"Voz ML","year":"2000","unstructured":"Voz ML, Agten NS, Van de Ven WJM, et al: PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res 60:106-113, 2000","journal-title":"Cancer Res"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01178-z"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.02.001"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0697"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01665-2"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20631"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02934-7"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2867-T"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4071"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-15-0316"},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72096-2"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2643"},{"key":"e_1_3_7_47_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI128227"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyad066"},{"key":"e_1_3_7_49_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0937-4"},{"key":"e_1_3_7_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182002777"},{"key":"e_1_3_7_51_2","first-page":"1579","article-title":"MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma","volume":"54","author":"Xu LH","year":"2019","unstructured":"Xu LH, Zhao F, Yang WW, et al: MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma. Int J Oncol 54:1579-1590, 2019","journal-title":"Int J Oncol"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0008-8"},{"key":"e_1_3_7_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2015.3270"},{"key":"e_1_3_7_54_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139497"},{"key":"e_1_3_7_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31825485c5"},{"key":"e_1_3_7_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20881"},{"key":"e_1_3_7_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29910-4"},{"key":"e_1_3_7_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31828a6727"},{"key":"e_1_3_7_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.08.004"},{"key":"e_1_3_7_60_2","doi-asserted-by":"publisher","DOI":"10.1177\/1093526621998869"},{"key":"e_1_3_7_61_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00449"},{"key":"e_1_3_7_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02304-y"},{"key":"e_1_3_7_63_2","volume-title":"NTHL1 Tumor Syndrome","author":"Kuiper RP","year":"2020","unstructured":"Kuiper RP, Nielsen M, Voer RMD, et al: NTHL1 Tumor Syndrome. GeneReviews, 2020"},{"key":"e_1_3_7_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30197"},{"key":"e_1_3_7_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0427-1"},{"key":"e_1_3_7_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2023.102381"},{"key":"e_1_3_7_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01841-3"},{"key":"e_1_3_7_68_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-01795-w"},{"key":"e_1_3_7_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/cphg.93"},{"key":"e_1_3_7_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02697-7"},{"key":"e_1_3_7_71_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4"},{"key":"e_1_3_7_72_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.176601"},{"key":"e_1_3_7_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1016"},{"key":"e_1_3_7_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.08.016"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-25-00490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:10:59Z","timestamp":1761855059000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-25-00490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1200\/PO-25-00490"],"URL":"https:\/\/doi.org\/10.1200\/po-25-00490","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500490"}}